Many bodybuilders use this dosing during intense training blocks, bulking phases, or periods of increased volume
KPV appears to exert its effects via the peptide transporter PepT1 rather than classical melanocortin receptors
NaBPC157 (without effect on basal normal values) compared with L-arginine has both a mimicking effect (impaired L-NAME-blood pressure increase, applied prophylactically and decreased already raised L-NAME values, given at the time of the maximal L-NAME-blood pressure increase (i.e., 10 minutes after L-NAME)) and a preventative activity (L-arginine-induced moderate blood pressure decrease was prevented by NaBPC157 pre-treatment)
Their labels contain drug claims stating the products can diagnose, cure, mitigate, treat, or prevent disease
IBS is a function problem
Interstitial hypertension in human breast and colorectal tumors